Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apollo Medical Inc.

    NASDAQ: AMEH · Real-Time Price · USD
    40.82
    -0.88 (-2.11%)
    At close: Feb 23, 2024, 9:00 PM

    Apollo Medical Statistics

    Share Statistics

    Apollo Medical has 44.84M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 44.84M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 823

    FTD / Avg. Volume

    n/a
    		 0.39%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 29.46 and the forward PE ratio is null. Apollo Medical's PEG ratio is -0.81.

    PE Ratio

    n/a
    		 29.46

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.16

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.45

    P/FCF Ratio

    n/a
    		 22.48

    PEG Ratio

    n/a
    		 -0.81
    Financial Ratio History

    Enterprise Valuation

    Apollo Medical has an Enterprise Value (EV) of 1.27B.

    EV / Sales

    n/a
    		 1.11

    EV / EBITDA

    n/a
    		 9.54

    EV / EBIT

    n/a
    		 15.49

    EV / FCF

    n/a
    		 21.49

    Financial Position

    The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.42.

    Current Ratio

    n/a
    		 2.88

    Quick Ratio

    n/a
    		 2.88

    Debt / Equity

    n/a
    		 0.42

    Debt / EBITDA

    n/a
    		 1.72

    Debt / FCF

    n/a
    		 3.88

    Interest Coverage

    n/a
    		 13.16

    Financial Efficiency

    Return on Equity is 8.33% and Return on Invested Capital is 7.13%.

    Return on Equity

    n/a
    		 8.33%

    Return on Assets

    n/a
    		 4.68%

    Return on Invested Capital

    n/a
    		 7.13%

    Revenue Per Employee

    n/a
    		 $840,060.94

    Profits Per Employee

    n/a
    		 $33,165.2

    Employee Count

    n/a
    		 1,362

    Asset Turnover

    n/a
    		 1.18

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 40.88M

    Effective Tax Rate

    n/a
    		 47.19%

    Stock Price Statistics

    The stock price has increased by 2.9% in the last 52 weeks. The beta is 1.04, so Apollo Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.04

    52-Week Price Change

    n/a
    		 2.9%

    50-Day Moving Average

    n/a
    		 39.06

    200-Day Moving Average

    n/a
    		 35.15

    Relative Strength Index (RSI)

    n/a
    		 45.15

    Average Volume (20 Days)

    n/a
    		 208,841

    Income Statement

    In the last 12 months, Apollo Medical had revenue of 1.14B and earned 45.17M in profits. Earnings per share was 1.

    Revenue

    n/a
    		 1.14B

    Gross Profit

    n/a
    		 199.48M

    Operating Income

    n/a
    		 104.27M

    Net Income

    n/a
    		 45.17M

    EBITDA

    n/a
    		 133.35M

    EBIT

    n/a
    		 94.54M

    Earnings Per Share (EPS)

    n/a
    		 1
    Full Income Statement

    Balance Sheet

    The company has 288.03M in cash and 229.36M in debt, giving a net cash position of 58.66M.

    Cash & Cash Equivalents

    n/a
    		 288.03M

    Total Debt

    n/a
    		 229.36M

    Net Cash

    n/a
    		 58.66M

    Retained Earnings

    n/a
    		 182.42M

    Total Assets

    n/a
    		 1.07B

    Working Capital

    n/a
    		 273.27M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 82.13M and capital expenditures -22.94M, giving a free cash flow of 59.19M.

    Operating Cash Flow

    n/a
    		 82.13M

    Capital Expenditures

    n/a
    		 -22.94M

    Free Cash Flow

    n/a
    		 59.19M

    FCF Per Share

    n/a
    		 1.32
    Full Cash Flow Statement

    Margins

    Gross margin is 17.43%, with operating and profit margins of 9.11% and 3.95%.

    Gross Margin

    n/a
    		 17.43%

    Operating Margin

    n/a
    		 9.11%

    Pretax Margin

    n/a
    		 7.57%

    Profit Margin

    n/a
    		 3.95%

    EBITDA Margin

    n/a
    		 11.65%

    EBIT Margin

    n/a
    		 9.11%

    FCF Margin

    n/a
    		 5.17%

    Dividends & Yields

    AMEH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 3.39%

    FCF Yield

    n/a
    		 4.45%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AMEH.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 27, 2015. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Apr 27, 2015

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 4.59

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist